PMDA drug package insert
ミナカラ八味地黄丸錠
PMDA OTC drug · （株）ミナカラ · package insert Mar 12, 2024
Key facts
| Brand names | ミナカラ八味地黄丸錠 |
|---|---|
| Companies | 製造販売元／大峰堂薬品工業（株）,販売会社／（株）ミナカラ |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | 八味地黄丸（腎気丸，八味腎気丸，崔氏八味丸） |
| Package insert date | Mar 12, 2024 |
| PMDA document key | 180102_J2401000028 |
| PMDA company code | 180102 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: